Noninvasive assessment of liver fibrosis: Serum markers and transient elastography (FibroScan) Evaluación no invasiva de fibrosis hepática: Marcadores séricos y elastografía transitoria (FibroScan)

Noninvasive assessment of liver fibrosis: Serum markers and transient elastography (FibroScan) Evaluación no invasiva de fibrosis hepática: Marcadores séricos y elastografía transitoria (FibroScan)

Both the prognosis and potential treatment of chronic liver disease greatly depend on the progression of liver fibrosis, which is the ultimate outcome of chronic liver damage. Historically, liver biopsy has been instrumental in adequately assessing patients with chronic liver disease. Histological a...

Full description

Bibliographic Details
Main Authors:	J. C. Marín-Gabriel, J. A. Solís-Herruzo
Format:	Article
Language:	English
Published:	Aran Ediciones 2009-11-01
Series:	Revista Espanola de Enfermedades Digestivas
Subjects:	Liver fibrosis Liver biopsy Transient elastography FibroScan Serum markers
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082009001100006

Similar Items

Non-invasive diagnosis of liver fibrosis by FibroScan imaging
by: WANG Chunyan
Published: (2013-03-01)

Diagnostic values of FibroScan and FibroTouch for liver fibrosis: a comparative analysis
by: WU Na
Published: (2014-07-01)

A comparative study of FibroScan and B ultrasound in diagnosis of liver fibrosis
by: LIU Lingfeng
Published: (2014-10-01)

FibroTest联合FibroScan对慢性乙型肝炎肝纤维化的诊断价值
by: CHENG Xiaojing
Published: (2014-05-01)

Value of FibroScan in diagnosis of hepatic fibrosis in patients with HBeAg-negative chronic hepatitis B
by: LUO Junhua
Published: (2014-07-01)

Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis
by: Seyyedabbas Hashemi, et al.
Published: (2016-10-01)

Evaluation value of APRI index in liver fibrosis degree of patients with hepatitis B and its correlation with FibroScan check
by: Mao-Lin Li
Published: (2016-02-01)

Effects of liver inflammation on FibroScan diagnosis of hepatic fibrosis in patients with chronic hepatitis B
by: LIU Zhiquan
Published: (2013-05-01)

Significance of FibroScan examination in hepatitis B virus-infected patients with normal ALT
by: LIU Hongbo
Published: (2015-02-01)

Accuracy of Liver Fibrosis Degree Based on King’s Score to FibroScan in Chronic Hepatitis B
by: Yudi Andre Marpaung, et al.
Published: (2016-05-01)

Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
by: Xinyu Yang, et al.
Published: (2021-03-01)

Evaluation of liver fibrosis by transient elastography (FibroScan®) in rheumatic patients during methotrexate treatment
by: Hariklia Kranidioti, et al.
Published: (2016-01-01)

Diagnostic value of Transient Elastography (Fibroscan) in the evaluation of liver fibrosis in chronic viral hepatitis C: Comparison to liver biopsy
by: Mona El-Hariri, et al.
Published: (2017-06-01)

Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch
by: Serra JT, et al.
Published: (2020-03-01)

Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐aspartate aminotransferase score
by: Takeshi Hatanaka, et al.
Published: (2021-10-01)

Diagnostic Accuracy of FibroScan and Factors Affecting Measurements
by: Satoshi Oeda, et al.
Published: (2020-11-01)

Non-invasive evaluation of liver stiffness in nonalcoholic fatty liver disease: supersonic shear imaging, FibroScan or ARFI?
by: Coskun Ozturker, et al.
Published: (2016-12-01)

Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®)
by: Chi-Cervera Luis Alberto, et al.
Published: (2021-01-01)

Assessment of hepatic fibrosis in patients with rheumatoid arthritis on long-term methotrexate therapy using transient elastography
by: Abhishek Kumar, et al.
Published: (2018-01-01)

2D shear wave elastography (SWE) performance versus vibration-controlled transient elastography (VCTE/fibroscan) in the assessment of liver stiffness in chronic hepatitis
by: Ahmed M. Osman, et al.
Published: (2020-03-01)

Fibroscan<sup> ®</sup> : A noninvasive test of liver fibrosis assessment
by: Al-Ghamdi Abdullah
Published: (2007-01-01)

Value of FibroScan in noninvasive diagnosis of hepatic steatosis
by: CHEN Jing
Published: (2015-05-01)

Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe
by: Grace Lai-Hung Wong, et al.
Published: (2013-07-01)

Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapy Evaluación de la fibrosis hepática en pacientes con hepatopatía crónica C mediante elastografía transitoria: implicaciones para determinar la eficacia del tratamiento antiviral
by: J. Mendoza, et al.
Published: (2010-07-01)

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
by: Friedrich-Rust Mireen, et al.
Published: (2010-09-01)

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis
by: Friedrich-Rust, Mireen, et al.
Published: (2010)

Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years
by: Jing Zeng, et al.
Published: (2019-04-01)

Effect of FibroScan test in antiviral therapy for HBV-infected patients with ALT <2 upper limit of normal
by: Han Xian-Zhi, et al.
Published: (2020-06-01)

Assessment of liver fibrosis: Noninvasive means
by: Poynard Thierry, et al.
Published: (2008-01-01)

Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography
by: Cheng HS, et al.
Published: (2018-05-01)

Accuracy of FibroScan for diagnosis of primary liver cancer: a Meta-analysis
by: LI Mi, et al.
Published: (2016-02-01)

Personalized management of cirrhosis by non-invasive tests of liver fibrosis
by: Grace Lai-Hung Wong, et al.
Published: (2015-09-01)

Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
by: Taisa Grotta Ragazzo, et al.

Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection
by: Naoyuki Ueda, et al.
Published: (2020-09-01)

The Role Of Fibroscan In Detecting Hepatic Fibrosis Induced By Methotrexate
by: Iliescu Madalina, et al.
Published: (2017-02-01)

Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome
by: Semanti Chakraborty, et al.
Published: (2020-01-01)

Elastography for Hepatic Fibrosis Severity in Chronic Hepatitis B or C
by: Maria-Vasiliki Papageorgiou, et al.
Published: (2011-01-01)

Prediction of oesophageal varices in cirrhotic patients by measuring liver stiffness with fibroscan
by: Shahinul Alam, et al.
Published: (2016-08-01)

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
by: Leire Pérez-Latorre, et al.
Published: (2018-04-01)

Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation
by: Mohsen S. Elalfy, MD, PhD, et al.
Published: (2013-01-01)

Cannot write session to /tmp/vufind_sessions/sess_v10ekhct94rmhie2v83f2fbrb0